Agilon Health (NYSE:AGL) Releases Quarterly Earnings Results, Beats Estimates By $3.20 EPS

Agilon Health (NYSE:AGL) released its quarterly earnings results on Wednesday. The company reported $1.97 EPS for the quarter, topping analysts’ consensus estimates of ($1.23) by $3.20, FiscalAI reports. Agilon Health had a negative return on equity of 59.42% and a negative net margin of 1.45%. The business had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.46 billion.

Here are the key takeaways from Agilon Health’s conference call:

• Agilon raised its 2026 outlook after beating third-quarter guidance, now expecting approximately $5.88 billion in revenue and $150 million in adjusted EBITDA. The stronger outlook reflects higher risk-adjustment revenue and favorable first-half medical cost development, though the company assumes cost trends around 7% for the rest of the year.
• Third-quarter adjusted EBITDA was $64 million, compared with a $91 million loss a year earlier, and the medical services expense ratio improved to 88.5% from 104%. Results benefited from risk-adjustment true-ups, favorable prior-year development, ACO performance, and lower-than-expected medical costs.
• ACO membership is expected to grow approximately 40%–50% in 2027, reaching about 160,000 members, driven largely by expanded MSSP partnerships. Management expects this growth to support improving baseline ACO adjusted EBITDA, while emphasizing a measured approach to new partnerships.
• Medicare Advantage membership was 454,000, down about 10% year over year, reflecting previously announced market exits tied to the company’s profitability-focused contracting strategy. Management also expects 2027 contracting benefits to be more modest than in 2026, when it re-contracted roughly 80% of membership.
• Management cited progress in clinical pathways and quality, including a 3% increase in gap closure and 4.2-star performance on contracted-plan quality measures. It said these programs can improve care and reduce avoidable costs, but noted that implementation and performance still vary across partners.

Agilon Health Trading Down 4.8%

AGL traded down $5.52 during mid-day trading on Friday, hitting $108.25. The stock had a trading volume of 86,634 shares, compared to its average volume of 319,920. The stock’s fifty day simple moving average is $87.79 and its 200-day simple moving average is $66.29. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.08 and a quick ratio of 1.08. The firm has a market capitalization of $1.82 billion, a price-to-earnings ratio of -19.53 and a beta of 3.10. Agilon Health has a 1-year low of $7.48 and a 1-year high of $133.04.

Wall Street Analyst Weigh In

AGL has been the topic of a number of recent analyst reports. Citigroup raised Agilon Health from a “sell” rating to a “neutral” rating and boosted their price objective for the stock from $105.00 to $115.00 in a research note on Monday, August 10th. Royal Bank Of Canada set a $125.00 price objective on shares of Agilon Health in a research report on Tuesday, September 15th. JPMorgan Chase & Co. boosted their target price on shares of Agilon Health from $31.00 to $85.00 and gave the stock an “underweight” rating in a research note on Monday, August 24th. Benchmark reissued a “buy” rating and set a $140.00 price target (up from $95.00) on shares of Agilon Health in a research note on Thursday, August 6th. Finally, Robert W. Baird set a $116.00 price target on shares of Agilon Health in a report on Thursday, August 6th. Six research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Agilon Health presently has a consensus rating of “Hold” and a consensus price target of $102.25.

About Agilon Health

Agilon Health, Inc is a healthcare company that partners with independent primary care physicians to support the transition from fee-for-service medicine to value-based care. The company works with physician practices serving primarily older adults enrolled in Medicare Advantage and helps them manage the cost, quality and coordination of care for their patient populations.

Agilon provides a technology-enabled platform that includes population health analytics, clinical and administrative support, care coordination resources and practice-management capabilities.